当前位置: 首页 > 新闻资讯 > 产品文献 > "酶免"产品文献：Longshengzhi Capsules Improve Ischemic Stroke Outcomes and Reperfusion Injury via the Promotion of Anti-Inflammatory and Neuroprotective Effects in MCAO/R Rats

"酶免"产品文献：Longshengzhi Capsules Improve Ischemic Stroke Outcomes and Reperfusion Injury via the Promotion of Anti-Inflammatory and Neuroprotective Effects in MCAO/R Rats

酶免官方商城 / 2020-07-08

文献标题

Longshengzhi Capsules Improve Ischemic Stroke Outcomes and Reperfusion Injury via the Promotion of Anti-Inflammatory and Neuroprotective Effects in MCAO/R Rats

文献作者

Weinan Yang，Lincheng Zhang，Simiao Chen，Qigu Yao，Haihong Chen，Jing Zhou，Weiyan Chen，Lan He and Yuyan Zhang

发表时间

2020年3月9日

文献影响因子

1.984

使用的酶免试剂盒产品名称

大鼠白细胞介素1β(IL-1β)ELISA试剂盒
大鼠肿瘤坏死因子α（TNF-α）ELISA试剂盒

下一篇:"酶免"产品文献：Transcriptome analysis of healthy and fatty liver revealed that inhibition of SLCO1B3 induces abnormal liver metabolism and lipid synthesis
上一篇:"酶免"产品文献：Cordyceps polysaccharide ameliorates airway inflammation in an ovalbumin-induced mouse model of asthma via TGF-β1/Smad signaling pathway